An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Clinical trial NCT00337285 · COMPLETED

Trial details

NCT number: NCT00337285
Sponsor: New River Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder Attention Deficit Disorders With Hyperactivity Attention Deficit Hyperactivity Disorders

Start date: 2006-07-01
Primary completion: 2007-11-01
Enrollment: 349

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.